HomeCompareKEGS vs MRK

KEGS vs MRK: Dividend Comparison 2026

KEGS yields 1000000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KEGS wins by $4.7683925249533696e+36M in total portfolio value
10 years
KEGS
KEGS
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.7683925249533696e+36M
Annual income
$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00
Full KEGS calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KEGS vs MRK

📍 KEGS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKEGSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KEGS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KEGS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KEGS
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KEGS beats the other by $4,052,336,490,287,657,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KEGS + MRK for your $10,000?

KEGS: 50%MRK: 50%
100% MRK50/50100% KEGS
Portfolio after 10yr
$2.3841962624766848e+36M
Annual income
$2,383,727,347,228,033,600,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KEGS
No analyst data
Altman Z
-3.2
Piotroski
8/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KEGS buys
0
MRK buys
0
No recent congressional trades found for KEGS or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKEGSMRK
Forward yield1000000.00%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$4.7683925249533696e+36M$56.8K
Annual income after 10y$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$9,798.13
Total dividends collected$4.7683311610149396e+36M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KEGS vs MRK ($10,000, DRIP)

YearKEGS PortfolioKEGS Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$100,010,700$100,000,000.00$11,206$366.19+$100.00MKEGS
2$934,786,450,701$934,679,439,252.34$12,650$502.35+$934786.44MKEGS
3$8,165,787,108,578,292$8,164,786,887,076,042.00$14,407$694.19+$8165787108.56MKEGS
4$66,665,884,190,957,650,000$66,657,146,798,751,470,000.00$16,585$967.82+$66665884190957.63MKEGS
5$508,662,171,058,048,100,000,000$508,590,838,561,963,700,000,000.00$19,342$1,363.89+$508662171058048128.00MKEGS
6$3,627,235,248,428,489,700,000,000,000$3,626,690,979,905,457,600,000,000,000.00$22,913$1,947.19+$3.62723524842849e+21MKEGS
7$24,173,681,159,150,610,000,000,000,000,000$24,169,800,017,434,790,000,000,000,000,000.00$27,662$2,823.89+$2.417368115915061e+25MKEGS
8$150,567,402,861,454,640,000,000,000,000,000,000$150,541,537,022,614,370,000,000,000,000,000,000.00$34,159$4,173.35+$1.5056740286145463e+29MKEGS
9$876,477,100,281,847,600,000,000,000,000,000,000,000$876,315,993,160,785,800,000,000,000,000,000,000,000.00$43,337$6,308.80+$8.764771002818475e+32MKEGS
10$4,768,392,524,953,369,600,000,000,000,000,000,000,000,000$4,767,454,694,456,067,000,000,000,000,000,000,000,000,000.00$56,776$9,798.13+$4.7683925249533696e+36MKEGS

KEGS vs MRK: Complete Analysis 2026

KEGSStock

1812 Brewing Company Inc. is a venture capital and private equity firm specializing in, early venture, mid venture, late venture, emerging growth and restructuring investments. It also specializes in management buyouts, leveraged buyouts and growth capital transactions. The firm makes equity, equity-related, and debt investments in companies that require expansion capital and in companies pursuing acquisition strategies. It primarily focuses on retail, restaurant, beverages, consumer products, hospitality, media, business services, technology, agriculture-related business, energy and manufacturing industries. It typically invests companies with majority of operations in North America, with a particular focus on Northern New York, but it also considers investments in the Caribbean and in Central America & Mexico. It seeks to exit its investments after two to five years. 1812 Brewing Company Inc. was founded in 2002 and is based in Gouverneur, New York.

Full KEGS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KEGS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KEGS vs SCHDKEGS vs JEPIKEGS vs OKEGS vs KOKEGS vs MAINKEGS vs JNJKEGS vs ABBVKEGS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.